Christopher C. Schreiber - 07 Jun 2023 Form 4 Insider Report for MyMD Pharmaceuticals, Inc. (TNFA)

Role
Director
Signature
/s/ Christopher C. Schreiber
Issuer symbol
TNFA
Transactions as of
07 Jun 2023
Net transactions value
$0
Form type
4
Filing time
09 Jun 2023, 18:00:22 UTC
Previous filing
15 Oct 2021
Next filing
02 Jan 2025

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MYMD Employee Stock Option (Right to Buy) Award $0 +150,000 $0.000000 150,000 07 Jun 2023 Common Stock 150,000 $1.66 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options vest as follows: (i) one third on the date of grant; (ii) one third on the first anniversary of the date of grant; and (iii) one third on the second anniversary of the date of grant, provided that the Reporting Person remains employed by MyMD Pharmaceuticals, Inc. or a subsidiary on the applicable vesting date.